Teleflex’s (TFX) “Hold” Rating Reiterated at KeyCorp
Other equities analysts have also issued research reports about the company. Barclays PLC reaffirmed a buy rating on shares of Teleflex in a research report on Monday, June 26th. Zacks Investment Research raised Teleflex from a hold rating to a buy rating and set a $228.00 price target for the company in a research report on Friday, June 23rd. Needham & Company LLC reaffirmed a buy rating on shares of Teleflex in a research report on Friday, August 4th. Jefferies Group LLC reaffirmed a buy rating and issued a $230.00 price target on shares of Teleflex in a research report on Thursday, August 3rd. Finally, Deutsche Bank AG reaffirmed a buy rating and issued a $238.00 price target (up previously from $220.00) on shares of Teleflex in a research report on Wednesday, August 9th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the company. Teleflex has a consensus rating of Buy and an average price target of $246.00.
Shares of Teleflex (NYSE:TFX) traded up 2.47% during mid-day trading on Wednesday, hitting $232.75. 539,406 shares of the stock traded hands. The company’s 50-day moving average price is $211.66 and its 200 day moving average price is $202.56. Teleflex has a 1-year low of $136.53 and a 1-year high of $235.18. The company has a market capitalization of $10.48 billion, a PE ratio of 44.51 and a beta of 1.05.
Teleflex (NYSE:TFX) last posted its quarterly earnings results on Thursday, August 3rd. The medical technology company reported $2.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.91 by $0.13. The firm had revenue of $528.60 million during the quarter, compared to analyst estimates of $518.98 million. Teleflex had a return on equity of 16.12% and a net margin of 12.36%. Teleflex’s quarterly revenue was up 11.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.89 EPS. Equities research analysts forecast that Teleflex will post $8.28 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, September 15th. Shareholders of record on Tuesday, August 15th will be given a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 0.58%. The ex-dividend date of this dividend is Friday, August 11th. Teleflex’s dividend payout ratio (DPR) is 26.00%.
In other Teleflex news, Director Stephen K. M.D. Klasko sold 200 shares of the business’s stock in a transaction dated Tuesday, August 1st. The stock was sold at an average price of $208.41, for a total value of $41,682.00. Following the completion of the transaction, the director now owns 8,080 shares of the company’s stock, valued at approximately $1,683,952.80. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Gretchen R. Haggerty bought 1,000 shares of the firm’s stock in a transaction on Wednesday, June 21st. The stock was acquired at an average cost of $203.82 per share, with a total value of $203,820.00. Following the transaction, the director now owns 1,760 shares in the company, valued at approximately $358,723.20. The disclosure for this purchase can be found here. In the last three months, insiders sold 600 shares of company stock valued at $125,652. 2.39% of the stock is owned by insiders.
Large investors have recently modified their holdings of the business. Toronto Dominion Bank raised its position in Teleflex by 14.5% in the 2nd quarter. Toronto Dominion Bank now owns 552 shares of the medical technology company’s stock worth $115,000 after buying an additional 70 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt purchased a new position in Teleflex in the 1st quarter worth about $155,000. Advisory Services Network LLC raised its position in Teleflex by 933.8% in the 2nd quarter. Advisory Services Network LLC now owns 827 shares of the medical technology company’s stock worth $172,000 after buying an additional 747 shares during the last quarter. OLD Mutual Customised Solutions Proprietary Ltd. raised its position in Teleflex by 200.0% in the 1st quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 900 shares of the medical technology company’s stock worth $174,000 after buying an additional 600 shares during the last quarter. Finally, Cornerstone Capital Management Holdings LLC. purchased a new position in Teleflex in the 2nd quarter worth about $175,000. 90.50% of the stock is owned by institutional investors and hedge funds.
Teleflex Company Profile
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Receive News & Stock Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related stocks with our FREE daily email newsletter.